599 related articles for article (PubMed ID: 33110473)
1. Possible Susceptibility Genes for Intervention against Chemotherapy-Induced Cardiotoxicity.
Yang X; Li G; Yang T; Guan M; An N; Yang F; Dai Q; Zhong C; Luo C; Gao Y; Das S; Xing Y; Shang H
Oxid Med Cell Longev; 2020; 2020():4894625. PubMed ID: 33110473
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-(1-7) reduces doxorubicin-induced cardiac dysfunction in male and female Sprague-Dawley rats through antioxidant mechanisms.
Rahimi O; Kirby J; Varagic J; Westwood B; Tallant EA; Gallagher PE
Am J Physiol Heart Circ Physiol; 2020 Apr; 318(4):H883-H894. PubMed ID: 32083974
[TBL] [Abstract][Full Text] [Related]
3. Role of oxidative stress in cardiotoxicity of antineoplastic drugs.
Zhang X; Zhu Y; Dong S; Zhang A; Lu Y; Li Y; Lv S; Zhang J
Life Sci; 2019 Sep; 232():116526. PubMed ID: 31170418
[TBL] [Abstract][Full Text] [Related]
4. [Cardiotoxicity as undesired side effect in the treatment of breast cancer].
Gramatyka M
Postepy Hig Med Dosw (Online); 2014 May; 68():483-97. PubMed ID: 24864100
[TBL] [Abstract][Full Text] [Related]
5. Concepts in cardio-oncology: definitions, mechanisms, diagnosis and treatment strategies of cancer therapy-induced cardiotoxicity.
Wickramasinghe CD; Nguyen KL; Watson KE; Vorobiof G; Yang EH
Future Oncol; 2016 Mar; 12(6):855-70. PubMed ID: 26829050
[TBL] [Abstract][Full Text] [Related]
6. Personalized medicine in cardio-oncology: the role of induced pluripotent stem cell.
Sayed N; Ameen M; Wu JC
Cardiovasc Res; 2019 Apr; 115(5):949-959. PubMed ID: 30768178
[TBL] [Abstract][Full Text] [Related]
7. Cardiotoxicity of cancer chemotherapy: implications for children.
Simbre VC; Duffy SA; Dadlani GH; Miller TL; Lipshultz SE
Paediatr Drugs; 2005; 7(3):187-202. PubMed ID: 15977964
[TBL] [Abstract][Full Text] [Related]
8. Cardiac effects of anticancer therapy in the elderly.
Accordino MK; Neugut AI; Hershman DL
J Clin Oncol; 2014 Aug; 32(24):2654-61. PubMed ID: 25071122
[TBL] [Abstract][Full Text] [Related]
9. Management of Cancer Therapeutics-Related Cardiac Dysfunction.
Vallakati A; Konda B; Lenihan DJ; Baliga RR
Heart Fail Clin; 2018 Oct; 14(4):553-567. PubMed ID: 30266364
[TBL] [Abstract][Full Text] [Related]
10. Autophagy and cancer therapy cardiotoxicity: From molecular mechanisms to therapeutic opportunities.
Li M; Russo M; Pirozzi F; Tocchetti CG; Ghigo A
Biochim Biophys Acta Mol Cell Res; 2020 Mar; 1867(3):118493. PubMed ID: 31233802
[TBL] [Abstract][Full Text] [Related]
11. Improving the preclinical models for the study of chemotherapy-induced cardiotoxicity: a Position Paper of the Italian Working Group on Drug Cardiotoxicity and Cardioprotection.
Madonna R; Cadeddu C; Deidda M; Mele D; Monte I; Novo G; Pagliaro P; Pepe A; Spallarossa P; Tocchetti CG; Zito C; Mercuro G
Heart Fail Rev; 2015 Sep; 20(5):621-31. PubMed ID: 26168714
[TBL] [Abstract][Full Text] [Related]
12. Imaging methods for detection of chemotherapy-associated cardiotoxicity and dysfunction.
Ong DS; Scherrer-Crosbie M; Coelho-Filho O; Francis SA; Neilan TG
Expert Rev Cardiovasc Ther; 2014 Apr; 12(4):487-97. PubMed ID: 24650314
[TBL] [Abstract][Full Text] [Related]
13. Oxidative stress in anticancer therapies-related cardiac dysfunction.
Attanasio U; Pirozzi F; Poto R; Cuomo A; Carannante A; Russo M; Ghigo A; Hirsch E; Tocchetti CG; Varricchi G; Mercurio V
Free Radic Biol Med; 2021 Jun; 169():410-415. PubMed ID: 33930514
[TBL] [Abstract][Full Text] [Related]
14. Left Ventricular Dysfunction and Chemotherapeutic Agents.
Clasen SC; Wald JW
Curr Cardiol Rep; 2018 Mar; 20(4):20. PubMed ID: 29520629
[TBL] [Abstract][Full Text] [Related]
15. Current and proposed biomarkers of anthracycline cardiotoxicity in cancer: emerging opportunities in oxidative damage and autophagy.
Dickey JS; Rao VA
Curr Mol Med; 2012 Jul; 12(6):763-71. PubMed ID: 22292442
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular toxicity of biologic agents for cancer therapy.
Bhave M; Akhter N; Rosen ST
Oncology (Williston Park); 2014 Jun; 28(6):482-90. PubMed ID: 25134321
[TBL] [Abstract][Full Text] [Related]
17. Metabolic Imaging in Cardio-oncology.
Tong D; Zaha VG
J Cardiovasc Transl Res; 2020 Jun; 13(3):357-366. PubMed ID: 31696405
[TBL] [Abstract][Full Text] [Related]
18. Cardio-oncology Part I: chemotherapy and cardiovascular toxicity.
O'Hare M; Sharma A; Murphy K; Mookadam F; Lee H
Expert Rev Cardiovasc Ther; 2015 May; 13(5):511-8. PubMed ID: 25843285
[TBL] [Abstract][Full Text] [Related]
19. Rationale and design of the multidisciplinary team IntervenTion in cArdio-oNcology study (TITAN).
Pituskin E; Haykowsky M; McNeely M; Mackey J; Chua N; Paterson I
BMC Cancer; 2016 Sep; 16(1):733. PubMed ID: 27629548
[TBL] [Abstract][Full Text] [Related]
20. [Tumor effects on the heart and circulation].
Anker MS; Hadzibegovic S; von Haehling S
Internist (Berl); 2020 Nov; 61(11):1120-1124. PubMed ID: 33052455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
